אופטלגין זריקות

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

DIPYRONE 1 G / 2 ML

Verfügbar ab:

TEVA PHARMACEUTICAL INDUST.LTD

ATC-Code:

N02BB02

Darreichungsform:

SOLUTION FOR INJECTION

Verabreichungsweg:

I.M, I.V

Hergestellt von:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

Therapiegruppe:

METAMIZOLE SODIUM

Anwendungsgebiete:

As an analgesic: Optalgin injection, by intravenous administration, is indicated for the relief of severe and acute pain when oral treatment is not feasible or suitable, as in post-traumatic or post-surgical pain, biliary or renal colic, and pain associated with malignant diseases. Intravenous administration of dipyrone should be carried out slowly over a period of at least 5 minutes, followed by reasonable clinical observation. Intramuscular administration of dipyrone for relief of pain is not recommended.However, if medical circumstances require such administration, all due precautions should be exercised to permit reasonable clinical observation. As an antipyretic: Optalgin injection by intramuscular administration is indicated to lower temperature in life-threatening situations, when this cannot be achieved by other means. Hyperthermic patients in critical condition may also be treated in non-hospital environment, under close medical supervision.

Berechtigungsdatum:

2011-08-01